Canada markets open in 16 minutes

Generation Bio Co. (GBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.9500+0.0300 (+0.61%)
At close: 04:00PM EDT
4.9500 0.00 (0.00%)
After hours: 04:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close4.9200
Open4.9400
Bid4.2500 x 800
Ask7.8800 x 800
Day's Range4.8500 - 5.1300
52 Week Range3.9600 - 35.4050
Volume134,896
Avg. Volume419,031
Market Cap282.586M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results

    Company continues to optimize cell-targeted lipid nanoparticle (ctLNP) delivery system for nonviral genetic medicine applications in liver, retina and vaccines Cash balance of $337.0M expected to fund operations into 2024 CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and first quarter 2022 financial results. “We are making s

  • GlobeNewswire

    Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference

    CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11th at 11:00 a.m. ET. A live webcast of the presentation will be available on the investor section of the company’s web

  • GlobeNewswire

    Generation Bio to Participate in 42nd Annual Cowen Health Care Conference

    CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in the Gene Therapy panel discussion at the 42nd Annual Cowen Health Care Conference on Wednesday, March 9 at 12:50 p.m. ET. A live webcast of the panel will be available on the investor section of the company’s w